Literature DB >> 17096068

Accuracy of preoperative prediction of microinvasion of portal vein in hepatocellular carcinoma using superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography.

Ryohei Miyata1, Akihiro Tanimoto, Go Wakabayashi, Motohide Shimazu, Seishi Nakatsuka, Makio Mukai, Masaki Kitajima.   

Abstract

BACKGROUND: Our aim was to diagnose microinvasion of the portal vein in hepatocellular carcinoma from preoperative radiological findings and to construct a scoring system.
METHODS: Forty-seven patients (38 men and 9 women; median age, 66.8 years) who underwent hepatic resections for hepatocellular carcinoma were selected retrospectively. Microscopically, 22 had portal vein invasion (PVI) and 25 had no PVI. All patients were examined preoperatively with superparamagnetic iron oxide-enhanced magnetic resonance imaging and computed tomography during hepatic angiography (CTHA). Perilesional enhancement on T1-weighted imaging, tumorous arterioportal (AP) shunt, and corona enhancement (contrast enhancement of the adjacent liver appearing in the late phase of CTHA) were assessed. Relative risk for PVI in terms of clinical and tumor characteristics was also assessed. The relative contribution to PVI was determined by the coefficient of a stepwise logistic regression. Each variable was given a score relative to the coefficient.
RESULTS: On univariate analysis, distortion of corona, tumorous AP shunt, and tumor size indicated a higher prevalence of PVI. The PVI predictive score was calculated as: total score = (maximum size in cm) + (T1 ring; + = 1, - = 0) + (tumorous AP shunt; + = 3, - = 0) + (distortion of corona; + = 10, - = 0). The PVI (+) group score was four times that of the PVI (-) group (16 vs 4). At a cutoff score of 10, the sensitivity, specificity, and accuracy were 82%, 84%, and 86%.
CONCLUSIONS: Distortion of corona, tumorous AP shunt, and tumor size are good predictors of the risk of PVI. This scoring system is simple and worth using clinically.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096068     DOI: 10.1007/s00535-006-1890-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  26 in total

1.  Hepatic resection of hepatocellular carcinomas based on tumor hemodynamics.

Authors:  M Sakon; H Nagano; J Shimizu; M Kondo; S Nakamori; K Dono; K Umeshita; H Nakamura; T Murakami; M Monden
Journal:  J Surg Oncol       Date:  2000-03       Impact factor: 3.454

2.  The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells.

Authors:  Akihiro Tanimoto; Go Wakabayashi; Hiroshi Shinmoto; Shigeo Okuda; Sachio Kuribayashi; Makio Mukai
Journal:  J Magn Reson Imaging       Date:  2005-03       Impact factor: 4.813

3.  Pseudolesions at T1-weighted gradient-echo imaging after administration of superparamagnetic iron oxide: comparison with portal perfusion abnormalities at CT during arterial portography.

Authors:  J Scharf; V Hoffmann; T Lehnert; H Anselm; G M Richter; G W Kauffmann
Journal:  Radiology       Date:  1998-04       Impact factor: 11.105

4.  Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.

Authors:  P J Mergo; T Helmberger; A I Nicolas; P R Ros
Journal:  AJR Am J Roentgenol       Date:  1996-02       Impact factor: 3.959

5.  Superparamagnetic iron oxide-enhanced MR imaging for early and late radiation-induced hepatic injuries.

Authors:  H Yoshiokaa; Y Itai; Y Saida; K Mori; H Mori; T Okumura
Journal:  Magn Reson Imaging       Date:  2000-11       Impact factor: 2.546

6.  Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.

Authors:  Akihiro Tanimoto; Go Wakabayashi; Hiroshi Shinmoto; Seishi Nakatsuka; Shigeo Okuda; Sachio Kuribayashi
Journal:  J Gastroenterol       Date:  2005-04       Impact factor: 7.527

7.  Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium.

Authors:  M Hori; T Murakami; H Oi; T Kim; S Takahashi; M Matsushita; K Tomoda; Y Narumi; K Kadowaki; H Nakamura
Journal:  Acta Radiol       Date:  1998-03       Impact factor: 1.990

8.  Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

Authors:  E Adachi; T Maeda; K Kajiyama; N Kinukawa; T Matsumata; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

9.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

10.  Segmental intensity differences in the liver on MR images: a sign of intrahepatic portal flow stoppage.

Authors:  Y Itai; K Ohtomo; T Kokubo; Y Okada; T Yamauchi; H Yoshida
Journal:  Radiology       Date:  1988-04       Impact factor: 11.105

View more
  15 in total

1.  Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Authors:  Honsoul Kim; Mi-Suk Park; Jin Young Choi; Young Nyun Park; Myeong-Jin Kim; Kyung Sik Kim; Jin Sub Choi; Kwang-Hyub Han; EunJu Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

2.  Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging.

Authors:  C-T Chou; R-C Chen; C-W Lee; C-J Ko; H-K Wu; Y-L Chen
Journal:  Br J Radiol       Date:  2011-08-09       Impact factor: 3.039

3.  Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

Authors:  N Griffin; H Addley; E Sala; A S Shaw; L A Grant; H Eldaly; S E Davies; T Prevost; G J Alexander; D J Lomas
Journal:  Br J Radiol       Date:  2011-03-08       Impact factor: 3.039

4.  Preoperative application of systemic inflammatory biomarkers combined with MR imaging features in predicting microvascular invasion of hepatocellular carcinoma.

Authors:  Xun Xu; Shuwen Sun; Qiuping Liu; Xisheng Liu; Feiyun Wu; Chong Shen
Journal:  Abdom Radiol (NY)       Date:  2022-03-10

5.  Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.

Authors:  Ken Shirabe; Kiyoshi Kajiyama; Norifumi Harimoto; Hideaki Masumoto; Tatsuro Fukuya; Masafumi Ooya; Yoshihiko Maehara
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

6.  CT Image-Based Texture Analysis to Predict Microvascular Invasion in Primary Hepatocellular Carcinoma.

Authors:  Yueming Li; Xuru Xu; Shuping Weng; Chuan Yan; Jianwei Chen; Rongping Ye
Journal:  J Digit Imaging       Date:  2020-09-23       Impact factor: 4.056

7.  Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma.

Authors:  Youcai Li; Yin Zhang; Qi Fang; Xiaoyao Zhang; Peng Hou; Hubing Wu; Xinlu Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-01-08       Impact factor: 9.236

Review 8.  MRI features of hepatocellular carcinoma related to biologic behavior.

Authors:  Eun-Suk Cho; Jin-Young Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

9.  Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.

Authors:  Chen Jue; Wu Zhifeng; Zhang Zhisheng; Cui Lin; Qian Yayun; Jin Feng; Gu Hao; Ishikawa Shintaro; Tadashi Hisamitsu; Guo Shiyu; Liu Yanqing
Journal:  Oncotarget       Date:  2016-11-22

10.  C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion.

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Justin Sangwook Ko; Jae Berm Park; Joon Hyeok Lee; Sung Joo Kim; Seung Woon Paik; Cheol-Keun Park
Journal:  World J Surg Oncol       Date:  2013-04-23       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.